Preparation and induction of immune responses by a DNA AIDS vaccine

Viral Immunology

Volumn 13, Issue 3, 2000, Pages 343-351

  Smith, J M ^a   Leung, N J ^a   Torres, J V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; DNA VACCINE; DNA VACCINE PIV; GLYCOPROTEIN GP 130; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; GENE DELETION; IMMUNE RESPONSE; NONHUMAN; RABBIT; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS PARTICLE;

ANIMALIA; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; MACACA MULATTA; ORYCTOLAGUS CUNICULUS; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0033808053     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/08828240050144662     Document Type: Article

References (30)

1. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques
2. Human immunodeficiency virus type 1 vif-mutant particles from restrictive cells: Role of vif in correct particle assembly and infectivity
3. A candidate live inactivatable attenuated vaccine for AIDS
4. Genetic immunization: A new era in vaccines and immune therapeutics
5. Replication of HIV type 1 in rabbit cell lines is not limited by deficiencies in tat, rev, or long terminal repeat function
6. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity
7. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
8. High-titer immune responses elicited by recombinant vaccinia virus priming and particle boosting are ineffective in preventing virulent SIV infection
9. DNA-based immunization
10. HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells
11. DNA vaccines against malaria: Immunogenicity and protection in a rodent model
12. Progression to AIDS in the absence of a gene for vpr or vpx
13. The immunopathogenesis of retroviral diseases: No immunophenotypic alterations in T, B, and NK cell subsets in SIVmac239-challenged rhesus macaques protected by SIV delta nef vaccination
14. Macaque models for AIDS vaccine development
15. Induction of vigorous cytotoxic T-lymphocyte responses by live attenuated simian immunodeficiency virus
16. DNA vaccines for parasitic infections
17. Detection of simian immunodeficiency virus (SIV)-specific CD8+ T cells in macaques protected from SIV challenge by prior SIV subunit vaccination
18. Vaccine evaluation studies of replication-defective SIVsmB7
19. Properties of virus-like particles produced by SIV-chronically infected human cell clones
20. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
21. Vaccine developments
22. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques
23. DNA vaccines
24. DNA vaccines for immunodeficiency viruses
25. Vigorous HIV-1-specific CD4 + T cell responses associated with control of viremia
26. Identification of a common clonal human immunodeficiency virus integration site in human immunodeficiency virus associated lymphomas
27. Rabbits transfused with human immunodeficiency virus type 1-infected blood develop immune deficiency with CD4+ lymphocytopenia in the absence of clear evidence for HIV type 1 infection
28. DNA vaccines for bacterial infections
29. Multi-epitope DNA vaccines
30. Vaccine protection by a triple deletion mutant of simian immunodeficiency virus